logo

For the Inventor, By the Inventor

Kusatsu, Japan

Teruya Nakamura

This inventor holds 26 USPTO granted patents, primarily in Antibiotic Development. Top assignees: Takara Shuzo Co., Inc., Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai, Nippon Shinyaku Company, Ltd.. Active years: 1977-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teruya Nakamura. Retrieved from https://idiyas.com/inventor/teruya-nakamura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26

% Patents Active = 100.0

Average Co-Inventor Count = 6.1

ph-index = 6

Forward Citations = 126(Granted Patents)


Location History:

  • Muko, JA (1977)
  • Muko, JP (1978)
  • Kyoto, JP (1980)
  • Shiga, JP (1988)
  • Kusatsu, JP (1984 - 1995)

Company Filing History:

goldMedal10 out of 190 
 
Takara Shuzo Co., Inc.
 patents
silverMedal10 out of 212 
 
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai
 patents
bronzeMedal6 out of 229 
 
Nippon Shinyaku Company, Ltd.
 patents
4. 2 out of 637 
 
Bristol-Myers Company
 patents
5. 1 out of 799 
 
Nippon Kayaku Kabushiki Kaisha
 patents
6. 1 out of 1 
 
Takara Shuzo Col., Ltd.
 patent
7. 1 out of 1 
 
Zaidan Hojin Biseibutsu Kagaku
 patent
where one patent can have more than one assignee

Years Active: 1977-1995

Loading Chart...
Areas of Expertise:
Restriction Enzyme
Aureobasidium Pullulans
Antibiotic R106
Spergualin Compounds
Immunosuppressing Method
Physiologically Active Substances
Guanidylfungin Derivatives
Carcinostatic Substance
Phenopicolinic Acid
Medical Composition
Side Effects Relief
2-Amino-2-Deoxy-D-Mannitol
26 patents (USPTO):Explore Patents
1. 5470732 - Restriction enzyme from Brevibacterium linens (1995-11-28),
2. 5260214 - Aureobasidium pullulans which produces antibiotic R106 (1993-11-09),
3. 5200505 - R106 compounds (1993-04-06),
4. 5158876 - Process for the production of antibiotic R106 by a strain of (1992-10-27),
5. 5057493 - Novel antibiotics R106 (1991-10-15),
6. 5002756 - Method for relieving radiogenic or drug-induced side effects (1991-03-26),
7. 4983328 - N-(4-(3-aminopropyl)aminobutyl)-2-(.omega.-gua (1991-01-08),
8. 4956504 - Novel spergualin-related compounds and process for producing the same (1990-09-11),
9. 4894344 - Method for manufacturing 2-amino-2-deoxy-D-mannitol (1990-01-16),
10. 4876244 - Medical composition for injection containing a spergualin as active (1989-10-24),
11. 4851446 - Immunosuppressing method (1989-07-25),
12. 4778824 - Method for suppressing a transplantation immunity and treating an (1988-10-18),
13. 4751217 - Physiologically active substances named SEN-366 (1988-06-14),
14. 4710517 - Medical composition for injection containing a spergualin as active (1987-12-01),
15. 4703128 - Guanidylfungin derivatives and their production (1987-10-27),

Title: **Teruya Nakamura: Innovator in Biotechnology**

Introduction

Teruya Nakamura, an esteemed inventor based in Kusatsu, Japan, has made significant contributions to the field of biotechnology with a total of 26 patents to his name. His innovative work primarily focuses on the development of advanced enzymes and antibiotics.

Latest Patents

Among Nakamura's latest patents is a remarkable restriction enzyme derived from Brevibacterium linens. This enzyme is cultivated from a specific strain and boasts the same specificity as AvrII, cleaving a nucleotide sequence precisely at designated sites. Additionally, he holds a patent for an antibiotic, R106, which is represented by a specific general formula. This antibiotic is notable for its potential applications in treating bacterial infections, showcasing Nakamura's commitment to addressing healthcare challenges.

Career Highlights

Nakamura's impressive career includes significant positions at renowned companies such as Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai and Takara Shuzo Co., Inc. His tenure at these institutions allowed him to cultivate his innovative ideas and push the boundaries of scientific research.

Collaborations

Throughout his career, Nakamura has collaborated with esteemed colleagues, including Tomio Takeuchi and Hamao Umezawa. These partnerships have fostered an environment of shared knowledge and creativity, propelling forward the advancements in their respective fields.

Conclusion

Teruya Nakamura stands out as a pioneering inventor within the biotechnology sector. His groundbreaking patents and collaborative efforts with fellow researchers have significantly enhanced our understanding and application of enzymes and antibiotics. As he continues to innovate, the impact of his work is sure to resonate throughout the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…